Stereotaxis Awarded $1.5 Million in Grants under the Qualifying Therapeutic Discovery Proje... ( ST. LOUIS Nov. 4 2010 /- Stereotaxis ...)

Stereotaxis Awarded $1.5 Million in Grants under the Qualifying Therapeutic Discovery Project Program

Date:11/4/2010

ST. LOUIS, Nov. 4, 2010 /PRNewswire/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced today that it has been awarded $1.5 million in grants under the Qualifying Therapeutic Discovery Project Program that was enacted under the Patient Protection and Affordable Care Act of 2010. The program targets projects that show potential to produce new therapies or medical technology that assists in the delivery or administration of therapeutics, addresses unmet medical needs and reduces the long-term growth of health care costs. Stereotaxis was awarded the grants for 2009 and 2010 projects related to the Company's Niobe® Remote Magnetic Navigation System and Odyssey™ system, which are designed to provide a safer and more effective healthcare solution for treating heart arrhythmias using magnetic catheters within the heart.

"We are pleased that the U.S. Department of Health and Human Services recognizes the potential impact that Stereotaxis' innovative technologies can have for patients suffering from diseases of the heart," said Michael P. Kaminski, President and Chief Executive Officer of Stereotaxis. "These grants will allow Stereotaxis to further enhance and expand the capabilities of our technology in an effort to treat the most common type of heart arrhythmias, atrial fibrillation, as well as ventricular tachycardia and other cardiovascular disorders."

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Niobe® Remote Magnetic Navigation System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment s
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Stereotaxis Reports Third Quarter Financial Results
2. Stereotaxis Appoints Industry Veteran as Head of EMEA Sales and Operations
3. Stereotaxis Announces Third Quarter 2010 Earnings Release Date and Conference Call
4. Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training
5. Stereotaxis Announces Third Quarter 2010 Capital Orders of $12.2 Million, Up 94 Percent Year-to-Year
6. Stereotaxis to Present at the JMP Securities Healthcare Conference
7. Stereotaxis Achieves Intellectual Property Milestone With 100th U.S. Patent
8. Stereotaxis to Present at the CL King Best Ideas Conference and the Stifel Nicolaus Healthcare Conference
9. Stereotaxis Announces First-Ever, Prospective, Comparative Clinical Trial Outcome for VT Patients
10. Stereotaxis Announces Second Quarter 2010 Earnings Release Date and Conference Call
11. New Data Demonstrate Safety, Efficacy of Stereotaxis for Patients with AFIB, VT and Congenital Defects

Post Your Comments:

(Date:5/17/2013)... , May 17, 2013 Atossa Genetics, Inc. (NASDAQ: ... Kyle Guse , Chief Financial Officer & ... MicroCap Conference on Thursday, May 30, 2013, in ... The Company,s presentation is scheduled to begin ... live webcast. To access the webcast, go to www.atossagenetics.com ...

(Date:5/16/2013)... and ZURICH , May 17, 2013 /PRNewswire/ ... Science, Technology and Research (A*STAR) and Switzerland,s ... volunteer has been dosed in a Phase 1 clinical trial ... bacteriophage Qbeta virus-like particle (VLP) technology. In this first Phase ... vaccine candidate and its potential to protect against H1N1 influenza ...

(Date:5/16/2013)... SYDNEY , May 16, 2013 HeartWare ... a leading innovator of less invasive, miniaturized circulatory support technologies ... announced that CEO Doug Godshall is ... at 11:00 a.m. EDT on Monday, May 20, 2013. The ... New York Hotel. A live webcast of the ...

Breaking Medicine Technology:Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2 Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6 HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2

[0] Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference [0] A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing [0] HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast

... ... ... ... ...

... ... ... , ... , , , ...

Cached Medicine Technology:Adamas Pharmaceuticals Announces In Vitro Data Demonstrating TCAD Therapy is More Potent Than Double Combinations or Monotherapy Against Drug-Resistant Flu Strains 2 Adamas Pharmaceuticals Announces In Vitro Data Demonstrating TCAD Therapy is More Potent Than Double Combinations or Monotherapy Against Drug-Resistant Flu Strains 3 Adamas Pharmaceuticals Announces In Vitro Data Demonstrating TCAD Therapy is More Potent Than Double Combinations or Monotherapy Against Drug-Resistant Flu Strains 4 Adamas Pharmaceuticals Announces In Vitro Data Demonstrating TCAD Therapy is More Potent Than Double Combinations or Monotherapy Against Drug-Resistant Flu Strains 5 Ritter Pharmaceuticals Joins NIH Conference Discussions on Lactose Intolerance and Associated Health Risks 2 Ritter Pharmaceuticals Joins NIH Conference Discussions on Lactose Intolerance and Associated Health Risks 3

Adamas Pharmaceuticals Announces In Vitro Data Demonstrating TCAD Therapy is More Potent Than Double Combinations or Monotherapy Against Drug-Resistant Flu Strains Ritter Pharmaceuticals Joins NIH Conference Discussions on Lactose Intolerance and Associated Health Risks

(Date:5/19/2013)... Buenos Aires, Argentina: Yoga classes ( clases de Yoga ... by the Sivananda Yoga Vedanta Center. The center ... Norte). Classes are 90 minutes and are offered all ... a calm environment, allowing visitors to enjoy the benefits ... among others. , The Yoga classes follow the following ...

(Date:5/19/2013)... (PRWEB) May 19, 2013 The legal ... website YazSideEffects.com in a concerted effort to connect women ... combination birth control drugs Yaz, Yasmin & Ocella with ... wealth of information on the notorious birth control drugs ... Bayer Pharmaceuticals. , Yaz, Yasmin & Ocella were ...

(Date:5/18/2013)... (PRWEB) May 18, 2013 Daily Gossip issued ... a new review on their page. John Colston, Daily Gossip’s ... to Shaun Hadsall’s revolutionizing 14-Day Rapid Fat Loss Plan ... sustain that carbs are healthy at a time when nutritionists ... from highly caloric products. , The diet is based ...

(Date:5/18/2013)... May 18, 2013 Also known as ... increasingly popular weight loss surgery that guarantees patients long-term ... Center wishes to give readers a brief tutorial ... attended medical school at New York City’s Mount Sinai ... Methodist he undertook a fellowship in Minimally Invasive Bariatric ...

(Date:5/18/2013)... May 18 (HealthDay News) -- Children who swallow high-powered ... remove the objects, according to a new study. ... in New Orleans, found that more than 79 percent ... either surgery or an endoscopic procedure, in which a ... tract. Only 21 percent of these cases can be ...

Breaking Medicine News(10 mins):Health News:Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center 2 Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2 Health News:Everything You Need to Know About Lap Band Surgery 2 Health News:Everything You Need to Know About Lap Band Surgery 3 Health News:Swallowing Magnets Can Be Fatal for Children 2

[0] Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center [0] Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers [0] 14 Day Rapid Fat Loss Plan Review of Shaun Hadsall's Diet and Workout Secrets Revealed By Daily Gossip [0] Everything You Need to Know About Lap Band Surgery [0] Swallowing Magnets Can Be Fatal for Children

... , , WOONSOCKET, R.I., ... not take their medications, but being busy or simply forgetting top the ... ten consumers (28%) sometimes forget to refill their prescriptions on time, and ... to a daily medication schedule. In addition, more than half (52%) ...

... , , , ... 13 As Americans are becoming increasingly aware of probiotics, ... and Prebiotics (ISAPP) provide increased clarity about the definition of ... percent) of Americans said they are aware of the term ...

... R.I., Aug. 13 CVS Caremark (NYSE: CVS ... examined consumer attitudes and behaviors around health care and prescription usage. ... coverage along with cost savings realized by improving health care delivery. , ... E75914LOGO ) , , Of all consumers ...

... , , , ... American Veterinary Medical Association (AVMA) is unveiling a new online pre ... multiple improvements to the tools and resources available to journalists. , , ... covering the complex and often controversial issues in veterinary medicine as easy as ...

... , ALLEGAN, Mich., Aug. 13 Perrigo ... its Board of Directors declared a quarterly dividend of $0.055 ... record on August 28, 2009. , , ... that develops, manufactures and distributes over-the-counter (OTC) and generic prescription ...

... Israel, Aug. 13 Shamir Optical Industry Ltd. (Nasdaq: ... and technology to the ophthalmic lens market, today announced unaudited financial ... , For the quarter ended June 30, 2009, revenues ... same period in 2008. The decrease in revenues was mainly due ...

CVS/pharmacy Helping Consumers with Challenge of Filling Prescriptions on Time New Guidelines Provide Clarity About Probiotics CVS Caremark Announces Results of 2009 Health IQ Study AVMA Unveils Improved Online Press Room to Help Journalists Perrigo Company Announces Quarterly Dividend Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results

... readers offering 96-channel parallel detection of fluorescence, ... 1,536-well microtiter plates. Compact workstations and ... the transport of microtiter plates with a ... The need for mechanical switching required by ...

... 1495-051 96PW washes all 96 ... and automatically. Separate wash and ... and excellent washing ability. Pre-programmed ... easily removable 96-channel head reduce ...

... SkanWasher 300 with ... system. Vacuum pressure and ... heights are adjustable. On-board ... configure 8 different programs. ...

... Automatic 96-well microplate washer ... Vacuum pressure, air pressure, and ... are adjustable. On-board software for ... programs. External vacuum pump required. ...

Medicine Products:

The UHTS system from Carl Zeiss Jena 96PW Microplate Washer SkanStacker (110V)SkanWasher 300 (110V)